mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.6 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |